Over the past 12 months, Ellab Group has acquired a quintet of European companies to consolidate its position as a leader in validation, calibration, and monitoring solutions for the pharmaceutical and biotech industries. Ellab has invested more than 23 million EUR in the five companies located in Ireland, Italy .